Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: Implications for prevention and therapy of viral diseases and cancer

Anticancer Research

Volumn 21, Issue 2 A, 2001, Pages 931-958

  Fernandez Pol, J A ^a   Hamilton, P D ^a   Klos, D ^a  

^a NONE   (United States)

Author keywords

AIDS virus; Chelating agents; Herpes virus; Metalloproteins; Picolinic acids

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; IRON; IRON CHELATING AGENT; METALLOPROTEIN; PICOLINIC ACID; VIRUS PROTEIN; ZINC FINGER PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; HERPES VIRUS; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION; VIRUS INFECTION; VIRUS MORPHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; APOPTOSIS; HUMANS; IRON; METALLOPROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PICOLINIC ACIDS; VIRUS DISEASES; ZINC FINGERS;

EID: 0035003223     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (185)

1. Zinc fingers are sticking together
2. Potential metal-binding domains in nucleic acid binding proteins
3. Zinc finger domains: Hypotheses and current knowledge
4. Zinc fingers and other metal-binding domains
5. Apoptosis, oncosis, and necrosis. An overview of cell death
6. Defining Apoptosis
7. Redefining cell death
8. To die or not to die: An overview of apoptosis and its role in disease
9. Cell suicide in health and disease
10. Apoptosis in the pathogenesis and treatment of disease
11. Apoptosis
12. Apoptosis: A product of programmed and unprogrammed cell death
13. Cell death via apoptosis and its relationship to growth. Development and differentiation of both tumour and normal cells
14. Apoptosis: The physiologic pathway of cell death
15. Apoptosis and disease
16. A model for processes combining competition with cooperation
17. Apoptosis 11: The molecular basis of apoptosis in disease
18. Regulation of apoptosis by human adenoviruses
19. Transcriptional and transforming activites of the adenovirus E1A proteins
20. Transcription activation by the adenovirus E1a protein
21. Apoptosis in development, tissue homeostasis, cancer and aging: How biological systems work and especially how they fail
22. The influence of zinc on apoptosis
23. A reappraisal of the role of zinc in life and death decisions of cells
24. A quantitative description of the cytostatic effects of chelators of transition metal ions (exemplified by picolinic acid and FE2+)
25. Apoptosis induced by niacin-related compounds in HL-60 cells
26. Vitamins and apoptosis -induction of apoptosis in human cancer cells by nicotinic acid-related compounds
27. The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells
28. Immunobiology of picolinic acid
29. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
30. In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA)
31. Studies with carboxyl-labeled 3-hydroxyanthranilic and picolinic acids in vivo an in vitro
32. Cell cycle kinetics of Chinese hamster (CHO) cells treated with the iron-chelating agent picolinic acid
33. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats
34. Clinical trials with 1-acetyl-2-picolinoylhydrazine (NSC-68626) in children
35. Iron nutrition and tumor growth: Decreased tumor growth in iron-deficient mice
36. Disproportionate accumulation of 18S and 28S ribosomal RNA in cultured normal rat kidney cells treated with picolinic acid or 5-methylnicotinamide
37. Iron: Its intracellular localization and possible role in cell division
38. Isolation and characterization of normal rat kidney cell membrane proteins with affinity for transferrin
39. The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines
40. Control of growth by picolinic acid: Differential response of normal and transformed cells
41. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture
42. Transition metal ions induce cell growth in NRK cells synchronized in G1 by picolinic acid
43. Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertanti subclone of sarcoma virus-infected mammalian cells
44. Morphological changes induced by picolinic acid in cultured mammalian cells
45. NRK cells synchronized in G(1) by picolinic acid are super-sensitive prostaglandin E(1) stimulation 74, 2
46. Peptide and protein complexes of transition metals as modulators of cellular replication
47. Iron transport in NRK cells synhronized in G(1) by picolinic acid
48. Transition metal ions induce cell growth in NRK cells synchronized in G(1) by picolinic acid
49. Selective toxicity induced by picolinic acid in simian virus 40-transformed cells in tissue culture
50. Isolation and characterization of a siderophore-like growth factor from mutants of SV40-transformed cells adapted to picolinic acid
51. Iron: Possible cause of the G1 arrest induced in NRK cells by picolinic acid
52. Selective toxicity induced by picolinic acid in simian virus 40-transformed cells in tissue culture
53. Regulation of apoptosis by viruses and zinc chelators antiviral agents: Implications for prevention and therapy of viral deseases and cancer
54. Oxidative DNA damage mediated by hormone and growth factor regulated iron finger proteins: Implications for prevention of cancer and aging
55. Molecular interactions of cancer and age
56. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells
57. Growth factors, oncogenes and aging
58. Growth factors, oncogenes, antioncogenes and aging
59. Characterization and quantitation of a zinc-binding ligand in human milk
60. Urinary excretion of chromium by humans following ingestion of chromium picolinate
61. Antitumor activity of picolinic acid in CBA/J mice
62. Transient growth inhibition of Escherichia coli K-12 by ion chelators: "In vivo" inhibition of ribonucleic acid synthesis
63. NRK cells synchronized in G1 by picolinic acid are super-sensitive to prostaglandin E1 stimulation
64. Increased membrane-associated nucleoside diphosphate kinase activity as a possible basis for enhanced guanine nucleotide-dependent adenylate cyclase activity induced by picolinic acid treatment of simian virus 40-transformed normal rat kidney cells
65. Angiogenesis and cancer control: From concept to therapeutic trial
66. Antiproliferative activity of picolinic acid due to macrophage activation
67. In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA)
68. Inhibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biologic response modifiers
69. Ribosomal RNA metabolism in macrophages
70. Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid
71. Picolinic acid, a catabolite of L-tryptophan is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages
72. IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages
73. Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of IFN-gamma-primed macrophages
74. Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans
75. Mode of action of Zn-complexes on herpes simplex virus type 1 infection in vitro
76. Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage
77. Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum
78. Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain. Evidence from turning behaviour and tysosine hydroxylase immunohistochemistry
79. Neurotoxicity of tryptophan metabolities
80. Picolinic acid modulates kainic acid-evoked glutamate release from the striatum in vitro
81. Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans
82. Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid
83. Inhibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biologic response modifiers
84. Effect of intracellular iron depletion by picolinic acid on expression of the lactorferrin receptor in the human colon carcinoma cell subclone HT29-18C
85. Chelating agent inhibition of Trypanosoma cruzi epimastigotes in vitro
86. Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicans
87. Zinc dependency as a cause of chronic diarrhea in variant acrodermatistis enteropatica
88. The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1a and - 1b in macrophages
89. Use of picolinic acid for orocutaneous herpes simplex eruptions
90. Macrophages control of mycrobacterial growth induced by picolinic acid is dependent on host cell apoptosis
91. Mode of action of Zn-complexes on Herpes simplex virus type 1 infections in vitro
92. In vivo and in vitro iron-replaced zinc finger generates free radicals and causes DNA damage
93. A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter
94. Extraribosomal functions of ribosomal proteins
95. The primary structures of rat ribosomal proteins S3a (The v-fos transformation effector) and of S3b
96. The primary structure of rat ribosomal protein L10: Relationship to a Jun-binding protein and to a putative Wilms' tumor suppressor
97. Extraribosomal functions of ribosomal proteins
98. Structure and evolution of mammalian ribosomal proteins
99. Bryodin, a ribosome-inactivating protein from the roots of Bryonia dioica L. (white bryony)
100. Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-aids activities from cucurbitaceae plants
101. Viral quasispecies
102. A growth factor-inducible gene encodes a novel nuclear protein with zinc-finger structure
103. Metallopanstimulin gene product produced in a Baculovirus expression system is a nuclear phosphoprotein that binds to DNA
104. Expression of metallopanstimulin in condylomata acuminata of the female anogenital region induced by papilloma virus
105. Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma
106. Differential expression of metallopanstimulin/S27 ribosomal protein in melanocytic lesions of the skin
107. Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cells lines: Confirmation of L7a and L37 over-expression in prostate-cancer tissue samples
108. The Hsp70 and Hsp60 chaperone machines
109. Resistance of Ehrlich tumor cells to apoptosis can be due to accumulation of heat shock proteins
110. Heat shock proteins increase resistance to apoptosis
111. Heat shock: The role of transient inducible responses in cell damage, transformation, and differentiation
112. Nuclear redistribution of BRCA1 during viral infection
113. Human papillomaviruses
114. Human papillomavirus and skin cancer
115. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: The role of local immmunosurveillance
116. Differences in transforming activity and coded amino acid sequence among E6 genes of several papillomaviruses associated with epidermodysplasia verruciformis
117. The role of papillomaviruses in human cancer
118. Papillomaviridae: Their viruses and their replication
119. Papillomaviruses
120. Nucleic acid binding by zinc finger-like motif of human papillomavirus type 16 E7 oncoprotein
121. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma
122. Papillomavirus infections- A major cause of human cancers
123. Human papillomaviruses
124. Herpesviridae
125. Antiviral agents
126. Improving HIV therapy
127. How drug resistance arises
128. Preventing HIV infection
129. Hepatitis C
130. Rotaviruses and their replication
131. Hepatitis C Viruses
132. Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants
133. In vitro study of the NS2-3 protease of hepatitis C virus
134. Desintegration of retroviruses by chelating agents
135. Preventing HIV-1 drug resistance
136. Novel zinc chelators which inhibit the binding of HIV-EP1 (HIV enhancer binding protein) to NF-kB recognition sequence
137. Solution conformation of the antitumor drug streptonigrin
138. Viral Proteases: Evolution of diverse structural motifs to optimize function
139. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses
140. Point mutants of moloney murine leukemia virus that fail to package viral RNA: Evidence for specific RNA recognition by a zinc-finger like protein sequence
141. Noninfectious human immunodeficiency virus Type 1 mutants deficient in genomic RNA
142. Characterization of moloney murine leukemia virus mutants with single amino acid substitutions in the Cys-His box of the nucleocapsid protein
143. 113 Cd NMR studies of 1: 1 Cd adduct with an 18-residue finger peptide from HIV-1 nucleic acid binding protein, p.7
144. Zinc fingers and molecular recognition. Structure and nucleic acid binding studies of an HIV zinc fingerlike domain
145. Induction of endonuclease-mediated apoptosis in tumor cells by C-nitroso-substituted ligands of poly (ADP-ribose) polymerase
146. 2+ coordination in ADP-ribose trasferase (polymerizing) by C-nitroso-1,2-benzopyrone coincidental with inactivation of the polymerase but not the DNA binding function
147. Inhibition of HIV-1 IIIb replication in AA-2 and MT-2 cells in culture by two ligands of poly (ADP-ribose) polymerase: 6-Amino-1,2-benzopyrone and 5-iodo-6-amino-1,2-benzopyrone
148. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent
149. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds
150. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS
151. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity
152. Inactivation of Murine Leukemia Virus by compounds that react with the zinc finger in the viral nucleocapsid protein
153. NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer
154. Inhibitors of human immuno-deficiency virus type 1-zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles
155. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: Effects on proteolytic processsing of gag precursors and particle formation
156. Viral RNA binding properties of human immunodeficiency virus type-2 (HIV-2) nucleocapsid protein-derived synthetic peptides
157. Genetic analysis of the zinc finger in the Moloney Murine Leukemia Virus nucleocapsid domain: Replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA
158. Comparative studies of the inhibitory, properties of antibiotics on human immunodeficiency virus and avian myeloblastosis virus reverse transcriptases and cellular DNA polymerases
159. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in Murine Leukemia Virus
160. DNA binding properties of the zinc-bound and zinc-free HIV nucleocapsid protein: Supercoiled DNA unwinding and DNA-protein cleavable complex formation
161. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein p7
162. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease
163. The ribonucleotide reductases - A unique group of metalloenzymes essential for cell proliferation
164. Herpes and human ribonucleotide reductases: Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87)
165. Ribonucleofide reductase encoded by Herpes Simplex Virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target
166. Inhibition of Herpes Simplex Virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives
167. Synthesis and inhibitory, potency of peptides corresponding to the subunit 2 C-terminal region of Herpes virus ribonucleotide reductases
168. KSHV and Kaposi's Sarcoma: The end of the beginning?
169. Ribonucleotide reductase inhibitors as anticancer and antiviral agents
170. Peptidomimetic inhibitors of herpes virus ribonucleotide reductase correlation between herpes simplex and varicella zoster virus
171. Deletion of the herpes simplex virus type I ribonucleotide reductase gene alters virulence and latency in vivo
172. A hepes simplex ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells
173. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3′-azido-3′-deoxythymidine on HIV type 1 infection in vitro
174. Inhibition of ribonucleotide reductase by 2′-substituted deoxycytidine analogs: Possible application in AIDS treatment
175. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
176. Alpha Interferon Inhibits Human Herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood Mononuclear cells
177. Viral RNA binding properties of human immunodeficiency virus type-2 (HIV-2) nucleocapsid protein-derived synthetic peptides
178. Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: Immunohistochemical and serological correlation with positron emission tomography
179. Ternary complex formation between V0(IV)-picolinic acid or VO(IV) -6methylpicolinic acid and small blood serum ligands
180. A structural role for metal ions in the "wild type" conformation of the tumor suppressor protein p53